Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

PHASE2CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

October 31, 2007

Conditions
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Interventions
BIOLOGICAL

Split, Inactivated, Trivalent Influenza Vaccine

Vaccine (infant dose)

BIOLOGICAL

Split, Inactivated, Trivalent Influenza Vaccine

Vaccine (children dose)

BIOLOGICAL

Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

Vaccine (infant dose)

BIOLOGICAL

Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

Vaccine (children dose)

Trial Locations (19)

15090

Wexford

15277

Pittsburgh

15401

Uniontown

16505

Erie

42303

Owensboro

44121

Cleveland

56401

Brainerd

71105

Shreveport

71111

Bossier City

72205

Little Rock

72432

Harrisburg

72472

Trumann

76107

Fort Worth

84109

Salt Lake City

84121

Salt Lake City

90241

Downey

90706

Bellflower

90723

Paramount

92708

Fountain Valley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY